Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Fluorouracil recalled?

Not under an active recall. Fluorouracil was recalled 23 times in the past — all now closed. Most recent: Dec 22, 2022.

Most common reason: Sterility / contamination (17 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Fluorouracil. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Fluorouracil recalls on record

none so far in 2026; 23 on record, newest first
Class II · Moderate risk

5-Fluorouracil 1%

Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.

Terminated Sterility / contamination Pharmacy Innovations D-0190-2023
Class II · Moderate risk

Fluorouracil

Lack of Processing Control

Terminated cGMP deviation The Medicine Shoppe Pharmacy D-1177-2020
Class I · High risk

Adrucil (fluorouracil injection, USP)

Presence of Particulate Matter: Black particulate matter was identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.

Terminated Particulate / foreign matter Teva Pharmaceuticals USA NDC 0703-3019-11 D-1089-2015
Class II · Moderate risk

5-Fluorouracil active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-497-2015
Class II · Moderate risk

5-Fluorouracil 1% ophthal

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Natures Pharmacy & Compounding Center D-1113-2014
Class II · Moderate risk

5-Fluorouracil pf in methocel 1% opthal

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

Terminated Sterility / contamination Natures Pharmacy & Compounding Center D-1112-2014
Class II · Moderate risk

FLUOROURACIL* PF 50 mg/mL INJECTABLE

Lack of Assurance of Sterility: All unexpired sterile compounded human and veterinary products are being recalled because they were compounded in the same environment and under the same practices as another product found to be non-sterile and therefore sterility cannot be assured.

Terminated Sterility / contamination Specialty Medicine Compounding Pharmacy D-421-2014
Class II · Moderate risk

Fluorouracil Topical Cream USP

Product Lacks Stability: Out-of-specification (OOS) results were observed for assay and description in retain samples.

Terminated Stability / shelf life Taro Pharmaceuticals U.S.A., Inc. NDC 51672-4118-6 D-086-2013
Class II · Moderate risk

Fluorouracil

Lack of Assurance of Sterility: Franck's Lab Inc. initiated a recall of all Sterile Human Drugs distributed between 11/21/2011 and 05/21/2012 because FDA environmental sampling revealed the presence of microorganisms and fungal growth in the clean room where sterile products were prepared.

Terminated Sterility / contamination Franck's Lab Inc., d.b.a. Franck's Compounding Lab D-1520-2012